Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

radiotherapeutics

Home Drugsradiotherapeutics

radiotherapeutics

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY
EP 3536345 A1Applicant: UNIV JOHNS HOPKINSPriority: 2014
CN
EP
US
WO
10 publications
IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN- (FAP- )
EP 3700580 A4Applicant: UNIV JOHNS HOPKINSPriority: 2017
CN
EP
US
WO
10 publications
RADIOTHERAPEUTIC MICROSPHERES
EP 3972566 A4Applicant: UNIV TEXASPriority: 2019
CN
EP
US
3 publications
FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF
EP 4598928 A1Applicant: RADIONETICS ONCOLOGY INCPriority: 2022
EP
US
WO
3 publications
GONADOTROPIN-RELEASING HORMONE RECEPTOR (GNRHR) TARGETED THERAPEUTICS AND USES THEREOF
EP 4634174 A1Applicant: RADIONETICS ONCOLOGY INCPriority: 2022
EP
US
WO
3 publications
Neuropeptide Y1 receptor (NPY1R) targeted therapeutics and uses thereof
US 12685789 B2Applicant: RADIONETICS ONCOLOGY INCPriority: 2023
US
WO
3 publications
Kisspeptin receptor (KISS1R) targeted therapeutics and uses thereof
US 12521455 B2Applicant: RADIONETICS ONCOLOGY INCPriority: 2024
US
WO
3 publications
NEUROTENSIN RECEPTOR 1 (NTSR1) TARGETED THERAPEUTICS AND USES THEREOF
US 20260207797 A1Applicant: RADIONETICS ONCOLOGY INCPriority: 2024
US
WO
2 publications
Modulators of the megalin-mediated uptake of radiotherapeutics and/or radiodiagnostics into kidney cells and their use in therapy and diagnostics
EP 1462119 A1Applicant: SCHERING AGPriority: 2003
EP
Modulator of the megalin-mediated uptake of radiotherapeutics and/or radiodiagnostics into kidney cells and their use in therapy and diagnostics
US 2004204357 A1Applicant: BRAUTIGAM MATTHIASPriority: 2004
US

Page 1 of 2